Latest News & Features
Americas
A major generic pharma company has failed to undo patents related to the oral suspension Quillivant XR. 8 July 2022
Big Pharma
The US Patent and Trademark Office and Food and Drug Administration have partnered to facilitate access to affordable drugs. 7 July 2022
Big Pharma
Germany-based CureVac has accused BioNTech of infringing four patents related to messenger ribonucleic acid technology. 7 July 2022
Americas
Licensing partners aim to prevent the introduction of a proposed eye drop generic treatment before the expiration of four patents. 5 July 2022
Big Pharma
The ruling marks the latest development of a long-running dispute over the alleged delay of a generic version of the blockbuster painkiller. 5 July 2022
article
The dispute centres on a process for extracting CBD from cannabis plant material, which anticipates the use of CBD as an anti-epileptic treatment. 5 July 2022
Big Pharma
The UK Supreme Court ruling involving Pfizer and Flynn is important for any company considering an appeal against the regulator, say Sophie Lawrance and James Batsford of Bristows. 30 June 2022
Big Pharma
Bristol-Myers Squibb claims violations under the Hatch-Waxman Act in an attempt to shut down generic. 30 June 2022
Big Pharma
Justice Mellor was unconvinced by arguments that Teva could have cleared the way. 30 June 2022
article
Many jurisdictions provide patent term extensions or Supplementary Protection Certificates in recognition of the fact that the time taken to achieve regulatory approval for patented products can often delay their release into the market. 30 June 2022